Patents by Inventor Xiankang FANG

Xiankang FANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Publication number: 20230201311
    Abstract: Disclosed herein are compositions comprising GLP-1 and/or GLP-1 analog(s) for treating or preventing non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: July 18, 2022
    Publication date: June 29, 2023
    Applicant: SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
    Inventors: Zhiqiang DU, Xiankang FANG, Qingqin LAI, Yan QIU, Peng WU
  • COMBINATIONAL THERAPY COMPRISING GLP-1 AND/OR GLP-1 ANALOGS, AND INSULIN AND/OR INSULIN ANALOGS
    Publication number: 20230092769
    Abstract: Disclosed herein are combinational therapies for diabetes comprising a first effective amount of one or more first active ingredients selected from the group consisting of GLP-1 and GLP-1 analogs and a second effective amount of one or more second active ingredients selected from the group consisting of insulin and insulin analogs.
    Type: Application
    Filed: July 18, 2022
    Publication date: March 23, 2023
    Applicant: SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
    Inventors: Yajun ZUO, Xiankang FANG, Zhiqiang DU, Jing XIA
  • DOSING REGIMEN OF GLP-1
    Publication number: 20230081034
    Abstract: Disclosed herein are dosing regimens of GLP-1 and/or GLP-1 analog(s).
    Type: Application
    Filed: July 18, 2022
    Publication date: March 16, 2023
    Applicant: SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
    Inventors: Huiqing SANG, Hai LU, Zhiqiang DU, Xiankang FANG